539268 Stock Overview
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally.
Syngene International Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹609.00|
|52 Week High||₹682.25|
|52 Week Low||₹508.10|
|1 Month Change||-0.55%|
|3 Month Change||0.85%|
|1 Year Change||3.19%|
|3 Year Change||91.99%|
|5 Year Change||121.90%|
|Change since IPO||292.40%|
Recent News & Updates
|539268||IN Life Sciences||IN Market|
Return vs Industry: 539268 exceeded the Indian Life Sciences industry which returned -27% over the past year.
Return vs Market: 539268 underperformed the Indian Market which returned 6.2% over the past year.
|539268 Average Weekly Movement||3.7%|
|Life Sciences Industry Average Movement||5.9%|
|Market Average Movement||5.6%|
|10% most volatile stocks in IN Market||9.1%|
|10% least volatile stocks in IN Market||3.6%|
Stable Share Price: 539268 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 539268's weekly volatility (4%) has been stable over the past year.
About the Company
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also offers exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services.
Syngene International Limited Fundamentals Summary
|539268 fundamental statistics|
Is 539268 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|539268 income statement (TTM)|
|Cost of Revenue||₹8.90b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Jan 23, 2023
|Earnings per share (EPS)||10.77|
|Net Profit Margin||15.21%|
How did 539268 perform over the long term?See historical performance and comparison